ANTH - Anthera Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1453,185-
Cost of Revenue---
Gross Profit1453,185-
Operating Expenses
Research Development46,25130,86021,839
Selling General and Administrative11,0717,5686,620
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-57,177-35,243-28,459
Income from Continuing Operations
Total Other Income/Expenses Net1,65423-96
Earnings Before Interest and Taxes-55,523-35,220-28,555
Interest Expense--1,049
Income Before Tax-55,523-35,220-29,604
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-55,523-35,220-29,604
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-55,523-35,220-29,604
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-66,437-35,220-29,604